Floatz logo

Epoetin Alfa

Prostate

Janssen-Ortho Inc., CanadaPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Prostate cohort.

Asset / SponsorPhaseRating
DINITROGEN MONOXIDE
Beth Israel Deaconess Medical Center
Phase 4BB
Oxygen
Beth Israel Deaconess Medical Center
Phase 4BB
Nivolumab
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2B
PSMA-HBED-CC ALF-18
Alessandro D'Agnolo
Phase 2B
Casodex
Memorial Sloan Kettering Cancer Center
Phase 2B

View all 27 →

Same molecule, other indications

Epoetin Alfa is also rated in:

anemiaDormant
BBB
Indicative ·
79 / 100
View asset →
plasma cell myelomaDormant
BB
Indicative ·
71 / 100
View asset →
precancerous conditionDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →